|
PRKCI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.553530E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.302300E-03 |
| Normal-vs-Stage2 |
8.616400E-04 |
| Normal-vs-Stage3 |
7.988100E-04 |
| Normal-vs-Stage4 |
8.2441000026634E-08 |
| Stage1-vs-Stage2 |
1.326840E-01 |
| Stage1-vs-Stage3 |
1.968380E-01 |
| Stage1-vs-Stage4 |
2.419300E-04 |
| Stage2-vs-Stage3 |
5.850200E-01 |
| Stage2-vs-Stage4 |
3.455000E-01 |
| Stage3-vs-Stage4 |
4.844100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.036400E-04 |
| Normal-vs-AfricanAmerican |
2.921400E-01 |
| Normal-vs-Asian |
1.678990E-03 |
| Caucasian-vs-AfricanAmerican |
5.305800E-01 |
| Caucasian-vs-Asian |
5.580200E-01 |
| AfricanAmerican-vs-Asian |
4.315800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.059200E-03 |
| Normal-vs-Female |
1.247110E-04 |
| Male-vs-Female |
5.827200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.360500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.447100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.815670E-04 |
| Normal-vs-Age(81-100Yrs) |
5.537700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.174420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.453900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.616800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.835400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.329800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.067600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.000300E-02 |
| Classical-VS-Follicular |
5.340500E-02 |
| Classical-VS-Other |
4.603400E-01 |
| Classical-VS-Normal |
1.055950E-02 |
| Tall-VS-Follicular |
9.829400E-01 |
| Tall-VS-Other |
9.386400E-01 |
| Tall-VS-Normal |
6.035000E-04 |
| Follicular-VS-Other |
9.518800E-01 |
| Follicular-VS-Normal |
3.216100E-04 |
| Other-VS-Normal |
4.759700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.16489999999414E-05 |
| Normal-vs-N1 |
1.604600E-03 |
| N0-vs-N1 |
9.821800E-01 |
|
|
